DeepKinZero

DeepKinZero applies zero-shot learning to predict which kinases phosphorylate protein sites, enabling kinase assignment for phosphosites when no prior phosphosite information exists.


Key Features:

  • Zero-shot learning: Enables prediction for kinases with no documented phosphosites by transferring information from characterized kinases.
  • Bidirectional recurrent neural network (RNN): Uses a bidirectional RNN to model sequence patterns around phosphosites.
  • Kinase-specific positional amino acid preferences: Learns positional amino acid preferences specific to individual kinases to inform predictions.
  • Proteome-level phosphosite compatibility: Operates on phosphosites identified at the proteome level.
  • Improved predictive performance: Produces higher accuracy than baseline models and existing methods as reported.
  • Addresses phosphoproteome data sparsity: Targets the issue that over 95% of reported human phosphosites lack known kinase associations.

Scientific Applications:

  • Phosphoproteome mapping: Assigns kinases to phosphosites to aid construction of the phosphoproteome atlas.
  • Characterization of understudied kinases: Expands knowledge of kinases with limited or no prior substrate information.
  • Investigation of cellular processes and disease mechanisms: Supports research into kinase roles in signaling and diseases including cancer.

Methodology:

DeepKinZero employs a zero-shot learning framework using a bidirectional recurrent neural network to learn kinase-specific positional amino acid preferences and transfer knowledge from well-characterized kinases to predict kinases for phosphosites with no prior annotations.

Topics

Details

Tool Type:
command-line tool
Programming Languages:
Python
Added:
1/18/2021
Last Updated:
2/27/2021

Operations

Publications

Deznabi I, Arabaci B, Koyutürk M, Tastan O. DeepKinZero: zero-shot learning for predicting kinase–phosphosite associations involving understudied kinases. Bioinformatics. 2020;36(12):3652-3661. doi:10.1093/bioinformatics/btaa013. PMID:32044914. PMCID:PMC7320620.

PMID: 32044914
PMCID: PMC7320620
Funding: - NIH: R01-LM012980